Related Experiment Videos

Pulmonary arterial hypertension and the vasoconstrictive factor: is there still a role for vasodilator testing?

J Simon R Gibbs, John Wharton, Martin R Wilkins

European Heart Journal

|February 13, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Adaptive imatinib regimens can mitigate cumulative toxicity while sustaining hemodynamic benefit: A model-based simulation of the positioning imatinib for pulmonary arterial hypertension trial.

British journal of clinical pharmacology·2026

Predictive Power of Pulmonary Artery Stiffness - Right Ventricular Interplay, but not Pulmonary Vascular Resistance, in Mild Pulmonary Hypertension: A PVRI GoDeep meta-registry analysis.

Chest·2026

Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertension.

bioRxiv : the preprint server for biology·2026

Impaired SOX17 Expression Causes Endothelial Dysfunction and Pulmonary Arterial Hypertension by Insufficient Suppression of RUNX1.

bioRxiv : the preprint server for biology·2026

Hemodynamic and metabolomic responses to infusion of GLP-1 agonist exenatide in pulmonary arterial hypertension.

JCI insight·2026

Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.

Science translational medicine·2026

See all related articles